Clinical Research Facility

Lake Charles, Louisiana 70601

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Major Cardiovascular Events in Patients With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)
Status: Enrolling, Phase II
Updated: 2/25/2016
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Asthma Clinical Trial
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Assess Efficacy and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling, Phase III
Updated: 2/28/2014
mi
from
Lake Charles, LA
Click here to add this to my saved trials